phytic acid has been researched along with Alloxan Diabetes in 6 studies
Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.
Excerpt | Relevance | Reference |
---|---|---|
" Body weight, blood glucose, glycated haemoglobin, insulin, serum leptin, HOMA-insulin resistance scores, intestinal amylase activity, serum and faecal lipids and food and fluid consumption were measured." | 3.83 | The effect of combined inositol hexakisphosphate and inositol supplement in streptozotocin-induced type 2 diabetic rats. ( Bustamante, J; Dilworth, LL; Foster, SR; Lindo, RL; Omoruyi, FO, 2016) |
" The microspheres had a relative pharmacological bioavailability of 10." | 1.56 | Optimization of phytic acid-crosslinked chitosan microspheres for oral insulin delivery using response surface methodology. ( Kim, JU; Kim, T; Lee, H; Park, J; Roh, YH; Shahbaz, HM; Yang, K, 2020) |
"Type 2 diabetes was induced in three groups using high-fat diet combined with a single dose of streptozotocin (35mg/kg body weight, intraperitoneally)." | 1.46 | Pancreatic and renal function in streptozotocin-induced type 2 diabetic rats administered combined inositol hexakisphosphate and inositol supplement. ( Alexander-Lindo, RL; Dilworth, LL; Foster, SR; Omoruyi, FO; Thompson, R, 2017) |
"Phytic acid (PA) was used as a cross-linking agent for encapsulation of insulin in a chitosan matrix for oral delivery of insulin." | 1.37 | Oral delivery of insulin using chitosan capsules cross-linked with phytic acid. ( Cho, S; Ghafoor, K; Jeong, C; Lee, H; Park, J, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Kim, JU | 1 |
Shahbaz, HM | 1 |
Lee, H | 2 |
Kim, T | 1 |
Yang, K | 1 |
Roh, YH | 1 |
Park, J | 2 |
Foster, SR | 3 |
Dilworth, LL | 3 |
Thompson, RK | 1 |
Alexander-Lindo, RL | 2 |
Omoruyi, FO | 3 |
Thompson, R | 1 |
Bustamante, J | 1 |
Lindo, RL | 1 |
Jeong, C | 1 |
Ghafoor, K | 1 |
Cho, S | 1 |
Kuppusamy, A | 1 |
Muthusamy, U | 1 |
Thirumalaisamy, SA | 1 |
Varadharajan, S | 1 |
Ramasamy, K | 1 |
Ramanathan, S | 1 |
6 other studies available for phytic acid and Alloxan Diabetes
Article | Year |
---|---|
Optimization of phytic acid-crosslinked chitosan microspheres for oral insulin delivery using response surface methodology.
Topics: Administration, Oral; Animals; Caco-2 Cells; Chitosan; Diabetes Mellitus, Experimental; Drug Carrier | 2020 |
Effects of combined inositol hexakisphosphate and inositol supplement on antioxidant activity and metabolic enzymes in the liver of streptozotocin-induced type 2 diabetic rats.
Topics: Animals; Antioxidants; Bilirubin; Diabetes Mellitus, Experimental; Dietary Supplements; Enzyme Activ | 2017 |
Pancreatic and renal function in streptozotocin-induced type 2 diabetic rats administered combined inositol hexakisphosphate and inositol supplement.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Drug Thera | 2017 |
The effect of combined inositol hexakisphosphate and inositol supplement in streptozotocin-induced type 2 diabetic rats.
Topics: Amylases; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, T | 2016 |
Oral delivery of insulin using chitosan capsules cross-linked with phytic acid.
Topics: Administration, Oral; Animals; Capsules; Chitosan; Cross-Linking Reagents; Diabetes Mellitus, Experi | 2011 |
In vitro (α-glucosidase and α-amylase inhibition) and in vivo antidiabetic property of phytic acid (IP6) in streptozotocin- nicotinamide-induced type 2 diabetes mellitus (NIDDM) in rats.
Topics: alpha-Amylases; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Free Radical S | 2011 |